Works matching Myeloproliferative disorders

Results: 2117

Review of current classification, molecular alterations, and Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophiliatyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia

Published in:

Journal of Blood Medicine, 2013, v. 4, p. 111, doi. 10.2147/JBM.S33142

By:

Havelange, Violaine;
Demoulin, Jean-Baptiste

Publication type:

Article

A Philadelphia-negatív krónikus myeloproliferativ kórképek epidemiológiai jellemzői Szabolcs-Szatmár-Bereg megyében. 33 év adatainak elemzése.

Published in:

Hungarian Medical Journal / Orvosi Hetilap, 2017, v. 158, n. 15, p. 572, doi. 10.1556/650.2017.30701

By:

Jakó, János;
Szerafin, László

Publication type:

Article

TRANSIENT MYELOPROLIFERATIVE DISORDER AND EOSINOPHILIC PERICARDIAL EFFUSION IN A DOWN SYNDROME NEONATE.

Published in:

Pediatric Hematology & Oncology, 2008, v. 25, n. 2, p. 123, doi. 10.1080/08880010801888220

By:

Shenoy, Rathika D.;
Bhat, Kamalakshi G.;
Kamath, Nutan;
Kumble, Yusuf

Publication type:

Article

HYDROPS FETALIS IN A NEONATE WITH DOWN SYNDROME, TRANSIENT MYELOPROLIFERATIVE DISORDER AND HEPATIC FIBROSIS.

Published in:

Fetal & Pediatric Pathology, 2007, v. 26, n. 5/6, p. 223, doi. 10.1080/15513810701818379

By:

Anuk, Deniz;
Tarcan, Aylin;
Alioglu, Bulent;
Avci, Zekai;
Haberal, Nihan;
Ozyurek, Emel;
Ozbek, Namik

Publication type:

Article

Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia.

Published in:

Modern Pathology, 2005, v. 18, n. 12, p. 1562, doi. 10.1038/modpathol.3800481

By:

O'Malley, Dennis P.;
Orazi, Attilio;
Mingsheng Wang;
Liang Cheng

Publication type:

Article

Does an Elevated Serum Vitamin B12 Level Mask Actual Vitamin B12 Deficiency in Myeloproliferative Disorders?

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 4, p. 269, doi. 10.1016/j.clml.2012.01.008

By:

Gauchan, Dron;
Joshi, Nitin;
Gill, Amandeep Singh;
Patel, Vishal;
DeBari, Vincent A.;
Guron, Gunwant;
Ma, Michael

Publication type:

Article

FAS/FASL gene polymorphisms in Turkish patients with chronic myeloproliferative disorders.

Published in:

2017

By:

Ozdemirkiran, Fusun Gediz;
Nalbantoglu, Sinem;
Gokgoz, Zafer;
Payzin, Bahriye Kadriye;
Vural, Filiz;
Cagirgan, Seckin;
Berdeli, Afig

Publication type:

journal article

Characteristics and Outcome of Primary Budd Chiari Syndrome due to Myeloproliferative Disorder in Egyptian Patients, A Single Center Study.

Published in:

QJM: An International Journal of Medicine, 2024, v. 117, p. ii428, doi. 10.1093/qjmed/hcae175.986

By:

Ibrahim, Amany Ahmed;
Mubarak, Hend;
El Ganzoury, Ahmed;
Hassan, Sarah;
Hakeem, Emad Abdel

Publication type:

Article

Chronic Myeloproliferative Disorders: The Role of Tyrosine Kinases in Pathogenesis, Diagnosis and Therapy.

Published in:

Pathobiology, 2007, v. 74, n. 2, p. 81, doi. 10.1159/000101707

By:

Macdonald, Donald;
Cross, Nicholas C.

Publication type:

Article

Effects of Immune Complexes on Holotranscobalamine Assay of Vitamin B12 Deficiency in Myeloproliferative Disorders.

Published in:

UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2019, v. 29, n. 1, p. 31, doi. 10.4999/uhod.193047

By:

CEKDEMIR, Demet;
CINEMRE, Fatma Behice Serinkan;
AYDEMIR, Birsen;
DILAVEROGLU, Nilgun;
CEKDEMIR, Yasin Ertug;
GUNDUZ, Mehmet;
CINEMRE, Hakan

Publication type:

Article

Observation and Management of Juvenile Myelomonocytic Leukemia and Noonan Syndrome-Associated Myeloproliferative Disorder: A Real-World Experience †.

Published in:

Cancers, 2024, v. 16, n. 15, p. 2749, doi. 10.3390/cancers16152749

By:

Lucas, Bryony J.;
Connors, Jeremy S.;
Wang, Heping;
Conneely, Shannon;
Cuglievan, Branko;
Garcia, Miriam B.;
Rau, Rachel E.

Publication type:

Article

Myeloproliferative Disorders with Translocations of Chromosome 5q31–35: Role of the Platelet-Derived Growth Factor Receptor Beta.

Published in:

Acta Haematologica, 2002, v. 107, n. 2, p. 113, doi. 10.1159/000046641

By:

Steer, E. Joanna;
Cross, Nicholas C.P.

Publication type:

Article

Cytogenetic Studies in Chronic Myeloproliferative Disorders.

Published in:

Acta Haematologica, 1983, v. 69, n. 3, p. 145, doi. 10.1159/000206880

By:

Carbonell, Felix;
Ganser, Arnold;
Heimpel, Hermann

Publication type:

Article

Oncogenic mechanisms in myeloproliferative disorders.

Published in:

Cellular & Molecular Life Sciences, 2006, v. 63, n. 24, p. 2939, doi. 10.1007/s00018-006-6272-7

By:

Delhommeau, F.;
Pisani, D. F.;
James, C.;
Casadevall, N.;
Constantinescu, S.;
Vainchenker, W.

Publication type:

Article

Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.

Published in:

Ultrasound in Obstetrics & Gynecology, 2001, v. 17, n. 5, p. 403, doi. 10.1046/j.1469-0705.2001.00384.x

By:

Smrcek, J. M.;
Baschat, A. A.;
Germer, U.;
Gloeckner-Hofmann, K.;
Gembruch, U.

Publication type:

Article

In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: Are they laboratory artefacts?

Published in:

Platelets, 2009, v. 20, n. 2, p. 131, doi. 10.1080/09537100802691544

By:

Grignani, Claudio;
Noris, Patrizia;
Tinelli, Carmine;
Barosi, Giovanni;
Balduini, Carlo L.

Publication type:

Article

Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.

Published in:

Platelets, 2006, v. 17, n. 5, p. 296, doi. 10.1080/09537100600746508

By:

Ryningen, Anita;
Apelseth, Torunn;
Hausken, Trygve;
Bruserud, Øystein

Publication type:

Article

Influence of the JAK2 V617F Mutation and Inherited Thrombophilia on the Thrombotic Risk among Patients with Myeloproliferative Disorders.

Published in:

Maedica - a Journal of Clinical Medicine, 2015, v. 10, n. 1, p. 27

By:

TEVET, Mihaela;
IONESCU, Razvan;
DRAGAN, Cornel;
LUPU, Anca Roxana

Publication type:

Article

Prevalence of JAK2 V617F mutation in Indian patients with chronic myeloproliferative disorders.

Published in:

Indian Journal of Medical Research, 2010, v. 132, n. 4, p. 423

By:

Sazawal, Sudha;
Bajaj, Jyoti;
Chikkara, Sunita;
Jain, Sonal;
Bhargava, Rahul;
Mahapatra, Manoranjan;
Saxena, Renu

Publication type:

Article

An acquired factor VIII inhibitor in association with a myeloproliferative/myelodysplastic disorder presenting with severe subcutaneous haemorrhage.

Published in:

Haemophilia, 2003, v. 9, n. 5, p. 638, doi. 10.1046/j.1365-2516.2003.00806.x

By:

Biss, T.;
Crossman, L.;
Neilly, I.;
Hanley, J.

Publication type:

Article

Chemotherapy for transient myeloproliferative disorder in a premature infant with Down syndrome.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2013, v. 38, n. 3, p. 262, doi. 10.1111/jcpt.12058

By:

Oztekin, O.;
Kalay, S.;
Tezel, G.;
Tayfun, F.;
Kupesiz, A.;
Hangul, M.;
Akcakus, M.;
Oygur, N.

Publication type:

Article

Low frequency of c-MPL gene mutations in Iranian patients with Philadelphia-negative myeloproliferative disorders.

Published in:

Iranian Journal of Pediatric Hematology & Oncology, 2015, v. 5, n. 1, p. 43

By:

Ghotaslou, A.;
Nadali, F.;
Chahardouli, B.;
Alizad Ghandforosh, N.;
Rostami, S. H.;
Alimoghaddam, K.;
Ghavamzadeh, A.

Publication type:

Article

TRANSIENT MYELOPROLIFERATIVE DISORDER WITH TRISOMY 12.

Published in:

Pediatric Hematology & Oncology, 2010, v. 27, n. 3, p. 233, doi. 10.3109/08880010903536193

By:

Basu, Biswanath;
Gupta, Vineeta

Publication type:

Article

Circulating microemboli in patients with myeloproliferative disorders.

Published in:

European Journal of Neurology, 2007, v. 14, n. 2, p. 199, doi. 10.1111/j.1468-1331.2006.01616.x

By:

Weber, C. A.;
Matzdorff, A. C.;
Gerriets, T.;
Villmow, T.;
Stolz, E.

Publication type:

Article

Chorea and Cognitive Impairment in JAK2V617F-Positive Myeloproliferative Disorders: A Case Report and Literature Review.

Published in:

2024

By:

Butnariu, Ioana;
Antonescu-Ghelmez, Dana;
Moraru, Adriana;
Anghel, Daniela Nicoleta;
Cojocaru, Florentina Melania;
Tuță, Sorin;
Ciobanu, Adela Magdalena;
Antonescu, Florian

Publication type:

Case Study

Ocular manifestations in leukemia and myeloproliferative disorders and their association with hematological parameters.

Published in:

Annals of African Medicine, 2016, v. 15, n. 3, p. 97, doi. 10.4103/1596-3519.188887

By:

Dhasmana, Renu;
Prakash, Amrita;
Gupta, Neeti;
Verma, S. K.

Publication type:

Article

Assessment of Endothelial Dysfunction With Flow-Mediated Dilatation in Myeloproliferative Disorders.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2018, v. 24, n. 7, p. 1102, doi. 10.1177/1076029618766260

By:

Yildiz, Abdulkerim;
Güryildirim, Melike;
Pepeler, Mehmet Sezgin;
Yazol, Merve;
Oktar, Suna Özhan;
Acar, Kadir

Publication type:

Article

The Relationship between the Myelodysplastic Syndromes and the Myeloproliferative Disorders.

Published in:

Leukemia & Lymphoma, 1999, v. 34, n. 5/6, p. 443, doi. 10.3109/10428199909058471

By:

Bain, Barbara J.

Publication type:

Article

Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder

Published in:

PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063152

By:

Xu, Dan;
Zheng, Hong;
Yu, Wen-Mei;
Qu, Cheng-Kui

Publication type:

Article

PEG-IFN-α-2b Therapy in BCR-ABL-negative Myeloproliferative Disorders.

Published in:

Cancer (0008543X), 2007, v. 110, n. 9, p. 2012, doi. 10.1002/cncr.23018

By:

Jabbour, Elias;
Kantarjian, Hagop;
Cortes, Jorge;
Thomas, Deborah;
Garcia-Manero, Guillermo;
Ferrajoli, Alessandra;
Faderl, Stefan;
Richie, Mary Ann;
Beran, Miloslav;
Giles, Francis;
Verstovsek, Srdan

Publication type:

Article

Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders.

Published in:

Hematology, 2009, v. 14, n. 6, p. 323, doi. 10.1179/102453309X12473408860226

By:

Basquiera, Ana L.;
Soria, Néstor W.;
Ryser, Ricardo;
Salguero, Miriam;
Moiraghi, Beatriz;
Sackmann, Federico;
Sturich, Ana G.;
Borello, Adriana;
Berretta, Adriana;
Bonafé, Miriam;
Barral, José Moreno;
Palazzo, Emilio D.;
García, Juan J.

Publication type:

Article

Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: A case report.

Published in:

Hematology, 2007, v. 12, n. 6, p. 489, doi. 10.1080/10245330701562204

By:

Sahin, Fahri;
Sercan, Zeynep;
Ertan, Yesim;
Ocakci, Serkan;
Ay, Ertan;
Vural, Filiz;
Yuksel, Erdinc;
Tombuloglu, Murat;
Saydam, Guray

Publication type:

Article

Classification of Ph-Negative Chronic Myeloproliferative Disorders - Morphology as the Yardstick of Classification.

Published in:

Pathobiology, 2007, v. 74, n. 2, p. 63, doi. 10.1159/000101706

By:

Kvasnicka, Hans Michael;
Thiele, Jürgen

Publication type:

Article

Histological and Molecular Classification of Chronic Myeloproliferative Disorders in the Age of JAK2: Persistence of Old Questions despite New Answers.

Published in:

Pathobiology, 2007, v. 74, n. 2, p. 72, doi. 10.1159/000099120

By:

Hussein, Kais;
Bock, Oliver;
Kreipe, Hans

Publication type:

Article

Janus kinase 2 mutations in cases with BCR-ABL-negative chronic myeloproliferative disorders from Turkey.

Published in:

Avicenna Journal of Medicine, 2017, v. 7, n. 1, p. 28, doi. 10.4103/2231-0770.197511

By:

Yildiz, Ismail;
Yokuş, Osman;
Gedik, Habip

Publication type:

Article

Complicated ventricular arrhythmia and hematologic myeloproliferative disorder in RIT1‐associated Noonan syndrome: Expanding the phenotype and review of the literature.

Published in:

Molecular Genetics & Genomic Medicine, 2020, v. 8, n. 7, p. 1, doi. 10.1002/mgg3.1253

By:

Aly, Safwat A.;
Boyer, Kenneth M.;
Muller, Brie‐Ann A.;
Marini, Davide;
Jones, Carolyn H.;
Nguyen, Hoang H.

Publication type:

Article

Platelet alpha-granule release in chronic myeloproliferative disorders with thrombocytosis.

Published in:

Scandinavian Journal of Clinical & Laboratory Investigation, 1986, v. 46, n. 2, p. 163, doi. 10.3109/00365518609083653

By:

Sacchi, S.;
Curci, G.;
Piccinini, L.;
Messerotti, A.;
Cucci, F.;
Bursi, R.;
Zaniol, P.;
Torelli, U.

Publication type:

Article

Advances in the understanding and management of myeloproliferative disorders.

Published in:

European Journal of Haematology, 2007, v. 79, p. 2, doi. 10.1111/j.1600-0609.2007.00934.x

By:

Skoda, Radek

Publication type:

Article

Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders.

Published in:

European Journal of Haematology, 2007, v. 79, p. 5, doi. 10.1111/j.1600-0609.2007.00935.x

By:

Skoda, Radek

Publication type:

Article

Phenotype and genotype in the myeloproliferative disorders.

Published in:

European Journal of Haematology, 2007, v. 79, p. 9, doi. 10.1111/j.1600-0609.2007.00936.x

By:

Spivak, Jerry L.

Publication type:

Article

Transcription factor Fli-1 expression by bone marrow cells in chronic myeloproliferative disorders is independent of an underlying JAK2 (V617F) mutation.

Published in:

European Journal of Haematology, 2006, v. 77, n. 6, p. 463, doi. 10.1111/j.0902-4441.2006.t01-1-EJH2826.x

By:

Bock, Oliver;
Hussein, Kais;
Neusch, Michael;
Schlué, Jerome;
Wiese, Birgitt;
Kreipe, Hans

Publication type:

Article

Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism.

Published in:

European Journal of Haematology, 2003, v. 71, n. 4, p. 276, doi. 10.1034/j.1600-0609.2003.00134.x

By:

Jensen, Morten Krogh;
Riisbro, Rikke;
Holten-Andersen, Mads N.;
Brown, Peter de Nully;
Junker, Peter;
Brunner, Nils;
Hasselbalch, Hans C.

Publication type:

Article

Increased circulating platelet–leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count.

Published in:

European Journal of Haematology, 2001, v. 66, n. 3, p. 143, doi. 10.1034/j.1600-0609.2001.00359.x

By:

Jensen, Morten Krogh;
de Nully Brown, Peter;
Lund, Birgit Villadsen;
Nielsen, Ove Juul;
Hasselbalch, Hans Carl

Publication type:

Article

Megakaryocyte c‐Mpl expression inchronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates.

Published in:

European Journal of Haematology, 2000, v. 65, n. 3, p. 170, doi. 10.1034/j.1600-0609.2000.90235.x

By:

Yoon, Soo‐Young;
Li, Chin‐Yang;
Tefferi, Ayalew

Publication type:

Article

A Fourth Case of 8p11 Myeloproliferative Disorder Transforming to B-Lineage Acute Lymphoblastic Leukaemia.

Published in:

Acta Haematologica, 2002, v. 107, n. 2, p. 98, doi. 10.1159/000046638

By:

JabbarAl-Obaidi, Magda;
Rymes, Nichola;
White, Paula;
Pomfret, Mark;
Smith, Hilary;
Starczynski, Jane;
Johnson, Rod

Publication type:

Article

Megakaryocytic Phagocytosis in a Chromosomally Normal Neonate with Transient Myeloproliferative Disorder.

Published in:

Acta Haematologica, 1991, v. 86, n. 1, p. 49, doi. 10.1159/000204800

By:

Lam, T.K.;
Prematilleke, M.N.;
Li, C.K.;
Fok, T.F.

Publication type:

Article

Acute Transformation in Nonleukemic Chronic Myeloproliferative Disorders: Actuarial Probability and Main Characteristics in a Series of 218 Patients.

Published in:

Acta Haematologica, 1991, v. 85, n. 3, p. 124, doi. 10.1159/000204873

By:

Cervantes, Francisco;
Tassies, Dolores;
Salgado, Camino;
Rovira, Montserrat;
Pereira, Arturo;
Rozman, Ciril

Publication type:

Article

Generation of Arachidonic Acid Metabolites from Stimulated Whole Blood in Patients with Chronic Myeloproliferative Disorders.

Published in:

Acta Haematologica, 1991, v. 85, n. 2, p. 88, doi. 10.1159/000204863

By:

Parise, P.;
Huybrechts, E.;
Grasselli, S.;
Falcinelli, F.;
Nenci, G.G.;
Gresele, P.;
Vermylen, J.

Publication type:

Article

Bone Marrow Stromal Cells in Myeloproliferative Disorders.

Published in:

Acta Haematologica, 1989, v. 82, n. 1, p. 35, doi. 10.1159/000205275

By:

Hirata, Jouji;
Takahira, Hiroyuki;
Kaneko, Shushi;
Nishimura, Junji;
Nawata, Hajime

Publication type:

Article

Platelet Lysosomal Enzymes Are Normal in Myeloproliferative Disorders.

Published in:

Acta Haematologica, 1984, v. 72, n. 3, p. 190, doi. 10.1159/000206385

By:

Leoncini, G.;
Balestrero, F.;
Maresca, M.;
Armani, U.;
Piana, A.

Publication type:

Article